|
Q2 FY2026
As of Aug 1, 2026
|
Q1 FY2026
As of May 2, 2026
|
Q4 FY2025
As of Jan 31, 2026
|
Q3 FY2025
As of Nov 1, 2025
|
Q2 FY2025
As of Aug 2, 2025
|
Q1 FY2025
As of May 3, 2025
|
Q4 FY2024
As of Feb 1, 2025
|
Q3 FY2024
As of Nov 2, 2024
|
Q2 FY2024
As of Aug 3, 2024
|
Q1 FY2024
As of May 4, 2024
|
Q4 FY2023
As of Feb 3, 2024
|
Q3 FY2023
As of Oct 28, 2023
|
Q2 FY2023
As of Jul 29, 2023
|
Q1 FY2023
As of Apr 29, 2023
|
Q4 FY2022
As of Jan 28, 2023
|
Q3 FY2022
As of Oct 29, 2022
|
Q2 FY2022
As of Jul 30, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 29, 2022
|
Q3 FY2021
As of Oct 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables, net of allowance for doubtful accounts $910 and $6,835 at August 1, 2026 and January 31, 2026, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued salaries and employee benefits | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Short-term lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term lease liabilities | ||||||||||||||||||||
| Deferred income tax liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock at $0.01 par value (100,000,000 shares authorized, 12,923,670 and 12,846,589 shares issued and outstanding at August 1, 2026 and January 31, 2026, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
